Miltenyi CliniMACS ( DrugBank: - )

3 diseases

ID	Disease name (Link within this page)	Number of trials
62	Paroxysmal nocturnal hemoglobinuria	1
65	Primary immunodeficiency	2
285	Fanconi anemia	1

62. Paroxysmal nocturnal hemoglobinuria

Clinical trials : 271 / Drugs : 163 - (DrugBank : 49) / Drug target genes : 22 - Drug target pathways : 106

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00143559 (ClinicalTrials.gov)	August 2005	1/9/2005	Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies	Haploidentical Hematopoietic Stem Cell Transplantation Utilizing Partial T-Cell Depletion as Immunotherapy for Hematologic Malignancies	Leukemia;Acute Lymphoblastic Leukemia;Acute Myeloid Leukemia;Chronic Myeloid Leukemia;Juvenile Myelomonocytic Leukemia;Myelodysplastic Syndrome;Paroxysmal Nocturnal Hemoglobinuria;Hodgkin's Lymphoma;Non-Hodgkin Lymphoma	Drug: Systematic chemotherapy and antibodies;Procedure: Allogeneic stem cell transplantation;Device: Miltenyi CliniMACS	St. Jude Children's Research Hospital	NULL	Completed	2 Years	21 Years	Both	17	Phase 2	United States

Clinical trials : 482 / Drugs : 653 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 212

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00160355 (ClinicalTrials.gov)	May 2005	8/9/2005	Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome	Haploidentical Hematopoietic Stem Cell Transplantation for Pediatric Patients With Wiskott-Aldrich Syndrome: A Pilot Study	Wiskott-Aldrich Syndrome	Procedure: Hematopoietic stem cell transplantation;Device: Miltenyi CliniMACS selection system;Drug: Fludarabine, Melphalan, Thiotepa	St. Jude Children's Research Hospital	NULL	Completed	N/A	18 Years	Male	4	Phase 1	United States
2	NCT00152100 (ClinicalTrials.gov)	February 2004	7/9/2005	Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome	Transplantation of Highly Purified Haploidentical CD133 Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome	Severe Combined Immunodeficiency	Procedure: Stem cell transplant;Drug: Filgrastim, Alemtuzumab;Device: Miltenyi CliniMACS	St. Jude Children's Research Hospital	NULL	Completed	N/A	2 Years	Both	4	Phase 1	United States

Clinical trials : 59 / Drugs : 118 - (DrugBank : 32) / Drug target genes : 31 - Drug target pathways : 155

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01082133 (ClinicalTrials.gov)	October 2009	5/3/2010	Multicenter Transplant Study for Fanconi Anemia	A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine	Fanconi Anemia	Drug: Chemotherapy;Biological: Miltenyi CliniMACS	Children's Hospital Medical Center, Cincinnati	NULL	Completed	N/A	N/A	Both	45	Phase 2	United States